Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7273
    +0.0010 (+0.14%)
     

  • CRUDE OIL

    83.34
    +0.61 (+0.74%)
     

  • Bitcoin CAD

    87,856.59
    +529.27 (+0.61%)
     

  • CMC Crypto 200

    1,375.52
    +62.90 (+4.79%)
     

  • GOLD FUTURES

    2,405.20
    +7.20 (+0.30%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6822
    +0.0001 (+0.01%)
     
MARKETS LIVE BLOG:

S&P 500 SLIPS BELOW 5,000; NASDAQ SINKS ON TECH DRAG

Nvidia tumbles 10%, Amazon loses more than 2% while Apple ends 1% lower

Coherus Management to Present at Upcoming Investor Conferences

Coherus BioSciences, Inc.
·1 min read

REDWOOD CITY, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will present at the following investor conferences in March.

  • 41st Annual Cowen Healthcare Conference on Monday, March 1 at 4 p.m. ET

  • Barclays Global Healthcare Conference on Tuesday, March 9 at 1:15 p.m. ET

The audio portion of the presentation will be available on the investors’ page of the Coherus BioSciences website at http://investors.coherus.com.

About Coherus BioSciences

Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system.

For additional information, please visit www.coherus.com.

Contact
McDavid Stilwell
EVP, Financial Strategy and IR
Coherus BioSciences, Inc.
mstilwell@coherus.com
+1 (650) 395-0152